TY - JOUR
AU - Banerjee, Abhik K.
AU - Blanco, Mario R.
AU - Bruce, Emily A.
AU - Honson, Drew D.
AU - Chen, Linlin M.
AU - Chow, Amy
AU - Bhat, Prashant
AU - Ollikainen, Noah
AU - Quinodoz, Sofia A.
AU - Loney, Colin
AU - Thai, Jasmine
AU - Miller, Zachary D.
AU - Lin, Aaron E.
AU - Schmidt, Madaline M.
AU - Stewart, Douglas G.
AU - Goldfarb, Daniel M.
AU - de Lorenzo, Giuditta
AU - Rihn, Suzannah J.
AU - Voorhees, Rebecca M.
AU - Botten, Jason W.
AU - Majumdar, Devdoot
AU - Guttman, Mitchell
PY - 2020
DA - October
TI - SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses
JO - Cell
EP - 1339
VL - 183
IS - 5
DO - http://dx.doi.org/10.1016/j.cell.2020.10.004
AB - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently identified coronavirus that causes the respiratory disease known as coronavirus disease 2019 (COVID-19). Despite the urgent need, we still do not fully understand the molecular basis of SARS-CoV-2 pathogenesis. Here, we comprehensively define the interactions between SARS-CoV-2 proteins and human RNAs. NSP16 binds to the mRNA recognition domains of the U1 and U2 splicing RNAs and acts to suppress global mRNA splicing upon SARS-CoV-2 infection. NSP1 binds to 18S ribosomal RNA in the mRNA entry channel of the ribosome and leads to global inhibition of mRNA translation upon infection. Finally, NSP8 and NSP9 bind to the 7SL RNA in the signal recognition particle and interfere with protein trafficking to the cell membrane upon infection. Disruption of each of these essential cellular functions acts to suppress the interferon response to viral infection. Our results uncover a multipronged strategy utilized by SARS-CoV-2 to antagonize essential cellular processes to suppress host defenses.
PB - Elsevier
UR - http://eprints.gla.ac.uk/225786/
KW - Coronavirus (COVID-19)
ER